by qfrsolutions | Mar 21, 2017 | News
Source: Cipher Pharmaceuticals Inc. (CPH.TO) (“Cipher” or “the Company”) announced today that veteran pharmaceutical industry executive Robert D. Tessarolo has been appointed President and Chief Executive Officer of Cipher, effective April 17 ,...
by qfrsolutions | Mar 17, 2017 | News
Source: Sun Pharmaceutical Industries today said an indirect arm of its group firm Taro will fully acquire Canada’s Thallion Pharmaceuticals for 2.7 million Canadian dollar. Taro Pharmaceuticals Inc (Canada) has entered into an agreement to acquire all of the...
by qfrsolutions | Mar 6, 2017 | News
Source: Novan MORRISVILLE, N.C., March 06, 2017 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that, after further analysis of the results from the NI-AC301 and NI-AC302 pivotal clinical trials for the Company’s topical...
by qfrsolutions | Feb 13, 2017 | News
Source: Since its massive Pfizer merger fell through last year, Allergan has persisted with “stepping-stone deals” rather than a transformational buy. Monday, the drugmaker unveiled its latest buy, Zeltiq, a $2.47 billion add-on for its aesthetics...
by qfrsolutions | Jan 27, 2017 | News
Source: Business Wire Encore Dermatology Inc., a privately held dermatology company that specializes in developing and commercializing novel prescription products for improving skin health, announced today the availability of TridesilonTM (desonide) Cream, 0.05% in a...
by qfrsolutions | Jan 26, 2017 | News
Source: Reuters U.S. healthcare giant Johnson & Johnson (JNJ.N) will buy Swiss biotech company Actelion (ATLN.S) in a $30 billion all-cash deal that includes spinning off Actelion’s research and development pipeline, the companies said on Thursday. The...
